Bacteremia in Patients with Hematological Malignancies

Publisher： Karger

E-ISSN： 1421-9794|51|2-3|147-153

ISSN： 0009-3157

Source： Chemotherapy, Vol.51, Iss.2-3, 2005-06, pp. : 147-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Addition of Teicoplanin or Vancomycin for the Treatment of Documented Bacteremia due to Gram-Positive Cocci in Neutropenic Patients with Hematological Malignancies: Microbiological, Clinical and Economic Evaluation

By  

Chemotherapy, Vol. 50, Iss. 2, 2004-06 ,pp. : 81-87

Karger

Access to resources Recommend Favorite

NF-κB in Hematological Malignancies

By Imbert Véronique   Peyron Jean-François  

Biomedicines, Vol. 5, Iss. 2, 2017-05 ,pp. : 27-27

MDPI

Access to resources Recommend Favorite

Systemic Infections with Candida sp. and Aspergillus sp. in Immunocompromised Patients with Hematological Malignancies: Current Serological and Molecular Diagnostic Methods

By  

Chemotherapy, Vol. 46, Iss. 3, 2000-04 ,pp. : 219-228

Karger

Access to resources Recommend Favorite

Extracellular Vesicles in Hematological Malignancies: From Biology to Therapy

By Caivano Antonella   La Rocca Francesco   Laurenzana Ilaria   Trino Stefania   De Luca Luciana   Lamorte Daniela   Del Vecchio Luigi   Musto Pellegrino  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1183-1183

MDPI

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies

By Ellis Leigh   Pili Roberto  

Pharmaceuticals, Vol. 3, Iss. 8, 2010-08 ,pp. : 2441-2469

MDPI

Access to resources Recommend Favorite